Saxonov Serge's Form 4 filing
10x Genomics, Inc. (TXG) · filed May 23, 2023
- Accession no.
- 0001610717-23-000062
- Filed
- May 23, 2023
- Trade date
- May 19-23, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $143.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Saxonov SergeCIK 0001786720 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 19, 2023 | Class A Common Stock | GGiftDisposed | −460 | $0.00 | $0 | 27 | Indirect | |
| May 23, 2023 | Class A Common Stock | SSaleDisposed | −534 | $55.06 | −$29,402.04 | 895,258 | Direct | |
| May 23, 2023 | Class A Common Stock | SSaleDisposed | −2,068 | $55.06 | −$113,864.08 | 893,190 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.